HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
4317studies shown
Showing 1,441-1,452 of 4,317
Drug study icon
RecruitingNCT07644052

PP-01, nabilone, or placebo for cannabis withdrawal

About this title

Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder

Read the official source — NCT07644052
Official study title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Clinical Trial of Titrating Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder: Core Study With Safety Extension Phase

Multiple locations, including Little Rock
AddictionMedication studyAges 18–55
Countries
United States
Sponsor
PleoPharma, Inc.
Drug study icon
RecruitingNCT07210112

Psilocybin with or without trazodone for treatment-resistant depression

About this title

Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

Read the official source — NCT07210112
Official study title

Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

In Paris
DepressionMedication studyAges 18+
Countries
France
Sponsor
Centre Hospitalier St Anne
Drug study icon
RecruitingNCT05133804

Reboxetine and methylphenidate for attention and emotional symptoms in PTSD

About this title

Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD

Read the official source — NCT05133804
Official study title

The Relation Between Attentional, Sensory and Emotional Dysregulation in Adults With Posttraumatic Stress Disorder: a Double-blind, Placebo-controlled Randomized Controlled Trial of the Combined Treatment With Reboxetine and Methylphenidate

Multiple locations, including Afula
PTSDMedication studyAges 20–60
Countries
Israel
Sponsor
University of Haifa
Behavioral study icon
RecruitingACTRN12624000776505

Efficacy of scalable approaches to reducing alcohol and other drug use among traumatised young people

Official study title

A randomised, parallel-group, non-inferiority trial to compare the efficacy of an integrated cognitive-behavioural therapy (COPE-A) for substance use and traumatic stress among adolescents and young adults delivered via telehealth versus in person

Multiple locations, including Westmead
PTSD, AddictionInterventional studyAges 12–25
Countries
Australia
Sponsor
The University of Sydney

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.